Recent Finacing
Recent Raise
Autolus is a London-based clinical-stage biopharmaceutical company developing engineered T-cell and CAR-T immunotherapies using a proprietary T-cell programming platform targeting haematological malignancies and solid tumors.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors